BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 20150167)

  • 1. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo.
    Wang J; Wang Y; Long J; Chang BH; Wilson MH; Overbeek P; Danesh FR
    Genesis; 2010 Jul; 48(7):446-51. PubMed ID: 20641128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a viral T2A-peptide based knock-in mouse model for enhanced Cre recombinase activity and fluorescent labeling of podocytes.
    Koehler S; Brähler S; Braun F; Hagmann H; Rinschen MM; Späth MR; Höhne M; Wunderlich FT; Schermer B; Benzing T; Brinkkoetter PT
    Kidney Int; 2017 Jun; 91(6):1510-1517. PubMed ID: 28187984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
    Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
    Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
    Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
    Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.
    Inoue S; Inoue M; Fujimura S; Nishinakamura R
    Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
    Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
    Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
    Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
    Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing Cre-recombinase specifically in retinal rod bipolar neurons.
    Zhang XM; Chen BY; Ng AH; Tanner JA; Tay D; So KF; Rachel RA; Copeland NG; Jenkins NA; Huang JD
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3515-20. PubMed ID: 16186328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific expression of Cre recombinase promotes glomerular basement membrane thickening.
    Balkawade RS; Chen C; Crowley MR; Crossman DK; Clapp WL; Verlander JW; Marshall CB
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1026-F1040. PubMed ID: 30810063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating conditional knockout mice.
    Friedel RH; Wurst W; Wefers B; Kühn R
    Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys.
    Heikkilä E; Juhila J; Lassila M; Messing M; Perälä N; Lehtonen E; Lehtonen S; Sjef Verbeek J; Holthofer H
    Nephrol Dial Transplant; 2010 Aug; 25(8):2437-46. PubMed ID: 20237062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.